ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 280 shares, the number of shares held increased 1.13% compared to the previous period and now represents 0.98% of the total position.

ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 38,355 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 1.96% of the total position.

ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.

ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 812 shares, the number of shares held decreased 3.03% compared to the previous period and now represents 1.02% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 178,906 shares, the number of shares held increased 1.44% compared to the previous period and now represents 1.97% of the total position.

ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 49,997 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 3.5% of the total position.

ARKG Investment Tracker position change: Increased position in Veeva by 730 shares, the number of shares held increased 1.14% compared to the previous period and now represents 1.27% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 168 shares, the number of shares held increased 0.62% compared to the previous period and now represents 1.03% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 13,546 shares, the number of shares held increased 0.11% compared to the previous period and now represents 2.13% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 56 shares, the number of shares held increased 0.22% compared to the previous period and now represents 0.89% of the total position.

ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 501,350 shares, the number of shares held decreased 3.95% compared to the previous period and now represents 2.05% of the total position.

ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 41,361 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 4.08% of the total position.

ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 31,213 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 9.61% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 28 shares, the number of shares held increased 0.1% compared to the previous period and now represents 0.98% of the total position.

ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 31,629 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 4.03% of the total position.

ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 85,289 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 3.57% of the total position.

ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 69,629 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 9.7% of the total position.

ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 70,557 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 4% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 1,400 shares, the number of shares held increased 5.72% compared to the previous period and now represents 0.94% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 252 shares, the number of shares held increased 0.98% compared to the previous period and now represents 1% of the total position.